Menu Back to DIA-CoRE-Singapore-Annual-Meeting-2021

Overview

"Catalysts for Changes – Preparing for the Future of Healthcare"

Technology driven innovations are creating a paradigm shift in healthcare and research post COVID-19

Healthcare needs to implement new technology and innovation in an unprecedented pace. A rapidly changing world demands efficient adoption of new tools and smart solutions. At the DIA-CoRE Singapore Annual Meeting, experts from around Asia unveil their best practice cases in technology implementation, covering all perspectives of the professional spectrum.

This online conference provides you the latest insights on how smart technology advances drug development, regulatory processes, and clinical trials. Hear from Asian industry professionals, pharmaceutical and medical technology innovators, as well as regulators how they have embraced new technologies to reinvent healthcare and its systems with the use of smart solutions. Experience applied knowledge and exclusive insights with keynotes, plenary sessions and townhall formats presented by leading experts from industry, science, and regulation.

How you can profit from this conference

    -Explore new technology adoptions in revolutionizing healthcare for better diagnostics and patient outcomes.

    -Receive updates on regulatory processes, policies, innovative drug review pathways, software regulations and adoption of virtual inspections.

    -Learn how clinical trials are taking a more patient centric approach and hear about the implementation of remote monitoring and it’s challenges in Asia.

    -Understand the regulations surrounding nutraceuticals/nutrition with its role in today’s healthcare.

    -Connect with the brightest minds in the region and discuss your ideas and insights with experts from regulatory authorities, academia and patient associations.

Featured topics

  • Explore new technology adoptions in revolutionizing healthcare for better diagnostics and patient outcomes
  • Receive updates on regulatory processes, policies, innovative drug review pathways, software regulations and adoption of virtual inspections.
  • Learn how clinical trials are taking a more patient centric approach and the implementation of remote monitoring in Asia and the challenges that arise.
  • ASEAN Townhall
  • Understand the regulations surrounding nutraceuticals/nutrition and its role in today’s healthcare

Who should attend?

  • Industry professionals in pharmaceuticals and medical technologies involved in Research & Development, Regulatory Affairs, Access and Medical Affairs.
  • Regulators and personnel from health authorities and ministries.
  • Representatives from patient associations and patient support groups.
  • Academia and researchers.

Program Committee

  • Dorothee  Grimald, PharmD
    Dorothee Grimald, PharmD Director, Global Regulatory Policy
    MSD, United States
  • James  Leong, PhD, MPharm
    James Leong, PhD, MPharm Head,Health Products & Regulatory Science Centre of Regulatory Excellence (CoRE)
    Duke NUS Medical School, Singapore
  • Audrey  Ooi, MSc
    Audrey Ooi, MSc Head- Business Development
    Clinical Research Malaysia, Malaysia
  • Finny  Liu, MSc, RPh
    Finny Liu, MSc, RPh APAC Regional Regulatory Policy Lead
    Roche Singapore Pte Ltd, Singapore
  • Jack  Wong
    Jack Wong Founder
    ARPA (Asia Regulatory Professionals Association) , Singapore
  • Mei  Ding
    Mei Ding JAPAC Regional Lead, Policy & Intelligence
    Abbvie Pte. Ltd., Singapore
  • Thean Soo  Lo
    Thean Soo Lo
    Regulatory Affairs Management Consultant, Singapore
  • Vicky  Hsu
    Vicky Hsu Corporate Vice President, Greater China Region Head and Head of Biotech Operatio
    Parexel International, United States
  • Yasha  Huang
    Yasha Huang Roche Diagnostics APAC
    Regulatory Affairs & Policy , Singapore
  • Senthil  Sockalingam
    Senthil Sockalingam M.D, Head of IQVIA Biotech, JAPAC, Chief Medical Officer, IQVIA, APAC
    IQVIA, United States
  • Shun  Jin, MBA
    Shun Jin, MBA Head, Regulatory Affairs, APMA
    Sandoz Asia Pacific Pharmaceutical Pte., Ltd., Singapore
  • Kum Cheun  Wong, PharmD
    Kum Cheun Wong, PharmD Head Asia Pacific Regulatory & Development Policy
    Novartis Asia Pacific Pharmaceuticals Pte. Ltd., Singapore
  • Jing Ping  Yeo, PhD
    Jing Ping Yeo, PhD Director, Research Integrity, Compliance and Ethics
    Singhealth, Singapore
  • Vicky (Fengyun)  Han
    Vicky (Fengyun) Han Senior Director, Asia Pacific Regulatory Policy Group Lead, Asia Pacific
    Johnson & Johnson Pte. Ltd., Singapore
Load More

Contact us

Registration Questions?


Send Email
+91 9029098844


Digital Learning Catalog

DIA Learning: eLearning Soultions
Download